Bio-Techne Corp Share Price

Bio-Techne Corp Share Price

NASDAQ: TECH | Large Cap
$72.69
+0.00 (0.00%) Last updated on 29 Oct, 2026 | 23:59 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Bio-Techne Corp Stock Performance

Open
$72.67
Prev. Close
$72.69
Circuit Range
N/A
Day Range
$72.65 - $72.72
Year Range
$43.21 - $72.75
Volume
98,477
Average Traded
$72.69

Bio-Techne Corp Share Price Today

As of 30 October 2026, Bio-Techne Corp's share price is $72.69. The stock opened at $72.67, compared to its previous close of $72.69. During today's trading session, Bio-Techne Corp's share price traded between $72.65 and $72.72, with an average price of $72.69. Over the past 52 weeks, the stock has recorded a high of $72.75 and a low of $43.21. In terms of performance, Bio-Techne Corp's share price has risen by 31.39% over the last six months and is up 16.20% on a year-on-year basis.

Bio-Techne Corp Share Price Chart

Line chart of the Bio-Techne Corp price trend over the selected period. The price rose overall, ranging from 72.65 to 72.72, ending at 72.69.
$72.65$72.72
L
Show Current Price
H

Bio-Techne Corp Stock Fundamentals & Key Indicators

Market Cap
$11.45B
PE Ratio (TTM)
62.68
Dividend Yield
0.44%
EPS (TTM)
$1.16
Revenue (TTM)
$1.22T
Return On Equity (TTM)
8.63%
Profit Margin
14.97%
Debt to Equity
0.09
Quarterly Earnings Growth YoY
43.02%

Bio-Techne Corp Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$286.56$295.88$311.42$321.19
Net Profit$38.19$38.01$51.05$54.62
Net Profit Margin13.33%12.85%16.39%17.01%
Income ChangeN/A-0.47%34.31%6.99%

Bio-Techne Corp Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$1136.70$1159.06$1219.64$1215.04
Net Profit$285.26$168.11$73.40$181.86
Net Profit Margin25.10%14.50%6.02%14.97%
Income ChangeN/A-41.07%-56.34%147.77%

About Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Corp Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$72.48
$72.69
+0.23%
Sep 2026
$72.36
$72.52
+0.07%
Aug 2026
$72.12
$72.47
+0.53%
Jul 2026
$70.78
$72.09
+2.05%
Jun 2026
$50.98
$70.64
+36.65%
May 2026
$54.49
$51.70
-6.55%
Apr 2026
$53.19
$55.32
+5.87%
Mar 2026
$57.98
$52.26
-11.45%
Feb 2026
$63.55
$59.01
-7.93%
Jan 2026
$58.82
$64.09
+8.98%
Dec 2025
$63.80
$58.81
-8.88%
Nov 2025
$61.80
$64.54
+3.18%

TECH Share Price FAQs